A Research Study for Patients With Metastatic Renal Cell Carcinoma

Clinical trial NCT00106613 · COMPLETED

Trial details

NCT number: NCT00106613
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell Neoplasm Metastasis

Start date: 2003-05-01
Primary completion: 2004-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.